Last Update Time:
18-Mar-2025 16:00:00
ISIN:
INE338H01029
Sector:
Healthcare
Symbol:
CONCORDBIO
Concord Biotech Limited
₹1,651.05
₹57.20
(3.59%)
▲
Prev. Close
₹1,593.85
Open
₹1,593.90
Close
₹1,651.35
Range
₹1,568.50 - ₹1,733.60
High
₹1,667.00
Low
₹1,593.90
Ind. Close
₹0.00
VWAP
₹1,634.04
The current stock price of Concord Biotech Limited is ₹1,651.05, with a target price range between ₹1,568.50 and ₹1,733.60. The stock has experienced a price change of ₹57.20 (3.59%), reflecting recent market volatility.
Today's opening price was ₹1,593.90, while the previous close stood at ₹1,593.85.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Concord Biotech Limited Price Chart
Concord Biotech Limited Pre Open Market Overview: 18-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1593.9
- Previous Close Price: 1593.85
- Change: 0.05%
- Total Traded Volume: 96
- Total Buy Quantity: 1,061
- Total Sell Quantity: 1,803
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,577.85 | 50.00 | 0.00 |
| 1,580.00 | 57.00 | 0.00 |
| 1,585.00 | 5.00 | 0.00 |
| 1,590.00 | 39.00 | 0.00 |
| 1,593.85 | 120.00 | 0.00 |
| 1,593.90 | 0.00 | 46.00 |
| 1,595.00 | 0.00 | 30.00 |
| 1,600.00 | 0.00 | 115.00 |
| 1,609.95 | 0.00 | 12.00 |
| 1,627.00 | 0.00 | 125.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 1061
Total Sell Quantity: 1803
Shareholding Patterns of Concord Biotech Limited
Key Trade Statistics of Concord Biotech Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.73 |
| Traded Value (₹ Cr.) | 11.94 |
| Total Market Cap (₹ Cr.) | 17,272.66 |
| Free Float Market Cap (₹ Cr.) | 5,441.72 |
| Impact cost | 0.1 |
| Quantity Traded | 73,056.00 |
| Deliverable Quantity | 33,246.00 |
| % of Quantity to Traded | 45.51 |
| Security VaR | 19.81 |
| Index VaR | N/A |
| VaR Margin | 19.81 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 23.31 |
| Face Value | 1 |
Key Price Statistics of Concord Biotech Limited
The 52-week high for Concord Biotech Limited was ₹2,664.00, recorded on 20-Sep-2024. On the other hand, the 52-week low stands at ₹1,327.05, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹1,912.60, and the lower band is ₹1,275.10. The price band is 20%.
The stock's daily volatility stands at 3.01, while the annualized volatility is 57.51. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (20-Sep-2024) | 2,664.00 |
| 52 Week Low (04-Jun-2024) | 1,327.05 |
| Upper Band | 1,912.60 |
| Lower Band | 1,275.10 |
| Price Band (%) | 20 |
| Daily Volatility | 3.01 |
| Annualised Volatility | 57.51 |
| Tick Size | 0.05 |
Key Securities Statistics of Concord Biotech Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 18-Aug-2023 |
| Adjusted P/E | 50.8 |
| Symbol P/E | 50.8 |
| Index | NIFTY 500 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Concord Biotech Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Concord Biotech Limited
| Subject | Date |
|---|---|
| Analysts/Institutional Investor Meet/Con. Call Updates | 18-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 10-Mar-2025 |
| Acquisition-XBRL | 04-Mar-2025 |
| Outcome of Board Meeting | 04-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 01-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 22-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 21-Feb-2025 |
| General Updates | 20-Feb-2025 |
Corporate Actions of Concord Biotech Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 1 | Dividend - Rs 8.75 Per Share | 21-Jun-2024 |
| 1 | Annual General Meeting | 21-Jun-2024 |
Board Meetings of Concord Biotech Limited
Financial Results of Concord Biotech Limited
Company Directory of Concord Biotech Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Head Office/ Corporate Office | 16th floor, B-Wing, Mondeal Heights Iscon Cross Road, S.G. Highway | AHMEDABAD |
| N/A | Registered Office | 1482-86, Trasad Road, Dholka | DHOLKA |
Insider Trading of Concord Biotech Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Prakash Lalchand Sajnani | 10844008 | Sell |
| 7(2) | Chandrashekhar Mukundrao Chawan | 2109400 | Sell |
| 7(2) | Devang Bhatt | 5204357 | Sell |
| 7(2) | Kanishka Kapoor | 144040200 | Sell |
| 7(2) | Ravi Kapoor | 0 | Sell |
| 7(2) | Raksha Modi | 2984731 | Sell |
| 7(2) | Rajendra Modi | 5998089 | Sell |
| 7(2) | UTPAL SHETH | 311449 | Buy |
| 7(2) | UTPAL SHETH | 1937488 | Buy |
Annual Reports of Concord Biotech Limited
Investor Complaints of Concord Biotech Limited
Event Calendar of Concord Biotech Limited
| Purpose | Details |
|---|---|
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Concord Biotech Limited
Voting Results of Concord Biotech Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 29-JUN-2024 | AGM | To receive, consider, approve and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended on 31st March, 2024 together with the Auditor and Directors Report thereon |
| 29-JUN-2024 | AGM | To declare dividend for the financial year 2023-24. |
| 29-JUN-2024 | AGM | To appoint Mr. Ravi Kapoor (DIN: 00003847) who retires by rotation and being eligible offers himself for reappointment as Director |
| 29-JUN-2024 | AGM | To Appoint M/s BSR & Co. LLP, Chartered Accountants for a term of 5 (Five) consecutive years from the conclusion of this Annual General Meeting till the conclusion of the Annual General Meeting for the financial year 2028-29. |
| 29-JUN-2024 | AGM | To ratify the remuneration of M/s Dalwadi & Associates, Cost Accountants for FY 2024-25 of INR 4,60,000 plus applicable Goods and Service Tax, p.a. and reimbursement of all reasonable out of pocket expenses incurred. |
FAQs on Concord Biotech Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.